M Pharmaceutical Inc. Announces Plans to Develop a Drug Product for Treatment of FSD
M Pharmaceutical Inc., (the "Company" or "M Pharma"), announced that, as part of its planned acquisition of 40 J's, it will continue to advance the development of a patented (additional patents pending) topical drug product for the treatment of female sexual dysfunction (FSD).
View full press release